| Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541) |
|---|
| 05/20/2003 | US6566554 Including amino benzothiophenones; useful for treatment of inflammatory diseases in which the production of cytokines is involved in the pathogenesis |
| 05/20/2003 | US6566537 Tolterodine |
| 05/20/2003 | US6566071 Useful as fluorescent labeling reagents |
| 05/20/2003 | US6565614 Cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing methods |
| 05/15/2003 | WO2003040143A1 Amine salts of an integrin receptor antagonist |
| 05/15/2003 | WO2003005965A3 Modulators of ceramidase and methods of use based thereon |
| 05/15/2003 | US20030092747 Secretase inhibitor |
| 05/15/2003 | CA2465416A1 Amine salts of an integrin receptor antagonist |
| 05/14/2003 | EP1309662A2 Triarylmethane dyes |
| 05/14/2003 | EP1309540A1 Oxidizing colorant |
| 05/13/2003 | US6563008 Biphenyl compounds and their use as oestrogenic agents |
| 05/13/2003 | US6563003 Process to produce amino alcohol salts |
| 05/13/2003 | US6562817 Suppressants of the IgE production |
| 05/13/2003 | US6562080 Primary intermediates for oxidative coloration of hair |
| 05/08/2003 | WO2003037879A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds |
| 05/08/2003 | WO2003037845A1 Compositions for treating acne comprising phytandiol amine |
| 05/08/2003 | US20030087963 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites |
| 05/08/2003 | US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol |
| 05/08/2003 | US20030087307 Compound for use in the prevention and treatment of respiratory and nervous system disorders |
| 05/08/2003 | US20030087306 Methods for identifying novel multimeric agents that modulate receptors |
| 05/08/2003 | CA2465061A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds |
| 05/07/2003 | EP1308435A2 Process for producing optically active amino alcohols |
| 05/07/2003 | EP1019358B1 3,3-diarylpropylamines , their use and preparation |
| 05/07/2003 | EP0986527B1 Reduction of carbonyl compounds by a silane in the presence of a zinc catalyst |
| 05/07/2003 | EP0940387B1 Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same |
| 05/06/2003 | US6559342 Method of producing alkanolamines and apparatus for producing same |
| 05/06/2003 | US6559261 A method for producing a polymeric material, said method comprising subjecting a starting material which includes two multiple bonds which are activated so that they will take part in a polymerisation reaction and wherein the multiple bonds |
| 05/06/2003 | US6558433 Oxidation hair dye |
| 05/02/2003 | EP0831799B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders |
| 05/02/2003 | EP0811006B1 Benzopyran-containing compounds and method for their use |
| 05/01/2003 | WO2003035599A1 Quarternary ammonium compounds and their use as antimuscarinic agents |
| 05/01/2003 | WO2002026701A3 Ionic liquids and their use as solvents |
| 05/01/2003 | US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/30/2003 | CN1414946A Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxy cyclohexyl) phenyl |
| 04/30/2003 | CN1414944A Process of preparing tolterodine and analogues thereof as well as intermediates prepared in the process |
| 04/30/2003 | CN1413976A New process for preparing levo-albuterol |
| 04/30/2003 | CA2409906A1 Process for producing optically active amino alcohols and intermediates therefor |
| 04/29/2003 | US6555497 Ammine solution |
| 04/24/2003 | WO2003033455A1 Oligoamine compounds and derivatives thereof for cancer therapy |
| 04/24/2003 | WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/24/2003 | CA2463771A1 Oligoamine compounds and derivatives thereof for cancer therapy |
| 04/23/2003 | EP1093450B1 Desformoterol and process for its preparation |
| 04/23/2003 | CN1413185A Substitued 1 and 2 naphthol mannich bases |
| 04/23/2003 | CN1413181A Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand |
| 04/23/2003 | CN1413104A New (aminopropyl) methylphosphinic acids |
| 04/23/2003 | CN1106389C Efficient enantioselective addition reaction using organozinc reagent |
| 04/23/2003 | CN1106388C Method and composition for regeneration of aminal compound |
| 04/22/2003 | US6552176 Salt forms of 6-n-butylamino-6-deoxy-α-L-sorbofuranose |
| 04/17/2003 | WO2003031389A1 Abscisic acid biosynthesis inhibitor |
| 04/17/2003 | US20030073731 Alkylation therapy; anticancer agent |
| 04/17/2003 | US20030070241 Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 04/17/2003 | CA2462689A1 Inhibitor against biosynthesis of abscisic acid |
| 04/16/2003 | EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/16/2003 | EP0968173B1 Process for the preparation of iodinated contrast agents and intermediates therefor |
| 04/16/2003 | CN1410416A Production method of isopropanolamine |
| 04/16/2003 | CN1410114A Production method of natural ephedra extract powder |
| 04/15/2003 | US6548534 Hydroxy and amine or amide compounds with substitution pattern on the aryl radical; can be used alone or in combination with estrogens in contraceptive preparations for treating gynecological disorders and premenstrual symptoms |
| 04/15/2003 | US6548523 Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties |
| 04/15/2003 | US6548484 An amidation product of ribosyl or glucosyl saccharide and a dopamine or derivative ( forms a amide through amine and carboxylic group); useful for treating neurological diseases including Parkinson's and related diseases |
| 04/10/2003 | WO2003029236A1 Process for the preparation of citalopram |
| 04/10/2003 | WO2003029169A2 Hydroxypropylamines |
| 04/10/2003 | WO2001066247A8 A nickel-rhenium catalyst for use in reductive amination processes |
| 04/10/2003 | US20030069288 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 04/10/2003 | CA2462851A1 Hydroxypropylamines |
| 04/10/2003 | CA2461213A1 Process for the preparation of citalopram |
| 04/09/2003 | EP1299373A1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
| 04/09/2003 | EP1299352A2 Compounds to treat alzheimer's disease |
| 04/09/2003 | EP1299349A2 Compounds to treat alzheimer's disease |
| 04/09/2003 | EP1299342A1 Method for producing 3,3-diarylpropylamines |
| 04/09/2003 | EP1051388B1 Method for producing optically active amino alcohols |
| 04/09/2003 | EP0896519B1 Colorants for colouring keratin fibres |
| 04/09/2003 | EP0876135B1 Dyeing agent for dyeing keratin fibres |
| 04/09/2003 | CN1409700A Process for preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties |
| 04/09/2003 | CN1408703A New phenyl ethyl amine compounds having beta 2-receptor excitation and its producing method |
| 04/03/2003 | WO2003027058A1 Sphingolipids |
| 04/03/2003 | WO2002081424A3 Chemical compounds derived from octopamine and their uses as beta 3-adrenergic agonists |
| 04/03/2003 | WO2002058632A3 Primary intermediates for oxidative coloration of hair |
| 04/03/2003 | US20030065224 Reacting ammonia with ethylene oxide in liquid phase |
| 04/03/2003 | US20030065219 Cyclization of an alcohol containing urea compound |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/03/2003 | CA2461801A1 Sphingolipids |
| 04/02/2003 | EP1296934A1 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
| 04/02/2003 | EP1296933A1 Self-reducible copper(ii) source reagents for chemical vapor deposition of copper metal |
| 04/02/2003 | EP0895471B1 Dyeing agent for dyeing keratin fibres |
| 04/02/2003 | EP0874615B1 Colorants for colouring keratin fibres |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541649 Process for synthesis of novel cationic amphiphiles containing N-hydroxyalkyl group for intracellular delivery of biologically active molecules |
| 04/01/2003 | US6541551 Resorcinolic derivative for rubber compounds |
| 04/01/2003 | US6541016 Monoalkyl phosphoric esters, dialkyl phosphoric esters, and, in small amounts, trialkyl phosphoric esters or salts, based on beta-branched fatty alcohols, effective in lowering the surface tension of both polar and nonpolar liquids |
| 04/01/2003 | US6540793 Coupler for use in oxidative hair dyeing |
| 03/28/2003 | WO2002030869A1 5-amino-1-pentene-3-ol substituted derivatives |
| 03/28/2003 | CA2424103A1 Substituted 5-amino-1-penten-3-ol derivatives |
| 03/27/2003 | US20030060641 1-(4- fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile is reacted with 3-(N,N-dimethylamino)propyl-chloride in the presence of methylsulfinylmethide as condensing agent, oxidizing to form citalopram |
| 03/27/2003 | US20030056303 Primary intermediate for oxidative coloration of hair |
| 03/27/2003 | DE20217570U1 Oxidative dyes for keratin fibers are based on a developer-coupler combination also containing (hetero)aromatic group-substituted 1,2-diaminobenzene derivatives, some of which are new compounds |
| 03/26/2003 | EP1296142A2 Calcium receptor active molecules |
| 03/26/2003 | EP1084099B1 Process for the preparation of protected 3-amino-1,2-dihydroxypropane acetal and derivatives thereof |
| 03/26/2003 | CN1406223A Protease inhibitor and their pharmaceutical uses |
| 03/20/2003 | WO2003022797A1 Carba-sugar amine derivatives and treatments for disorder of glycolipid metabolism containing the same as the active ingredient |
| 03/20/2003 | WO2003022259A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites |